These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2145371)

  • 1. [Hepatitis after treatment with cyproterone acetate. Apropos of a case].
    Dore B; Orget J; Irani J; Aubert J
    J Urol (Paris); 1990; 96(3):169-71. PubMed ID: 2145371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hepatitis caused by cyproterone acetate.
    Blake JC; Sawyerr AM; Dooley JS; Scheuer PJ; McIntyre N
    Gut; 1990 May; 31(5):556-7. PubMed ID: 2140997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatal subfulminant hepatitis caused by cyproterone acetate].
    Antoni M; Bourlière M; Toullec J; Maillot A; Botta-Fridlund D; Gauthier A
    Gastroenterol Clin Biol; 1991; 15(10):772-3. PubMed ID: 1840042
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute hepatitis induced by cyproterone acetate.
    Giordano N; Nardi P; Santacroce C; Geraci S; Gennari C
    Ann Pharmacother; 2001 Sep; 35(9):1053-5. PubMed ID: 11573856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hepatocellular dysfunction following cyproterone acetate therapy.
    Parys BT; Hamid S; Thomson RG
    Br J Urol; 1991 Mar; 67(3):312-3. PubMed ID: 1827039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe acute hepatitis due to cyproterone].
    Ruiz-Rebollo ML; Polo F; Palenzuela R; Moretó M
    Gastroenterol Hepatol; 1997; 20(7):385. PubMed ID: 9377242
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancers of the prostate and cyproterone acetate. Value of blood testosterone and PSA levels for treatment surveillance].
    Aubert J; Dore B; Irani J; Bon D
    J Urol (Paris); 1990; 96(8):431-5. PubMed ID: 1707083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant hepatitis due to cyproterone acetate.
    Lévesque H; Trivalle C; Manchon ND; Vinel JP; Moore N; Hémet J; Courtois H; Bercoff E; Bourreille J
    Lancet; 1989 Jan; 1(8631):215-6. PubMed ID: 2563116
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of cyproterone acetate in prostate cancer.
    Goldenberg SL; Bruchovsky N
    Urol Clin North Am; 1991 Feb; 18(1):111-22. PubMed ID: 1825143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hepatic necrosis in a patient treated with cyproterone acetate].
    Lombardi A; Ferrazza P; Castaldi F; Covotta L; Tesoriere A; Urbano V; Midiri G
    G Chir; 1998 Apr; 19(4):161-3. PubMed ID: 9628065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of prostatic cancer with cyproterone acetate as monotherapy.
    Beurton D; Grall J; Davody P; Cukier J
    Prog Clin Biol Res; 1987; 243A():369-77. PubMed ID: 2958861
    [No Abstract]   [Full Text] [Related]  

  • 12. Radical economic surgery and antiandrogenic therapy in management of prostatic cancer.
    Giuliani L
    Eur Urol; 1980; 6(5):272-4. PubMed ID: 6447070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases.
    Bessone F; Lucena MI; Roma MG; Stephens C; Medina-Cáliz I; Frider B; Tsariktsian G; Hernández N; Bruguera M; Gualano G; Fassio E; Montero J; Reggiardo MV; Ferretti S; Colombato L; Tanno F; Ferrer J; Zeno L; Tanno H; Andrade RJ
    Liver Int; 2016 Feb; 36(2):302-10. PubMed ID: 26104271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of symptomatic metastatic prostatic cancer with cyproterone acetate versus orchiectomy: a prospective randomized trial.
    Ostri P; Bonnesen T; Nilsson T; Frimodt-Møller C
    Urol Int; 1991; 46(2):167-71. PubMed ID: 1711250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatocellular damage by cyproterone acetate.
    Meijers WH; Willemse PH; Sleijfer DT; Mulder NH; Grond J
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1121-2. PubMed ID: 2946585
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyproterone-induced hepatotoxicity.
    Pinganaud G; Chaslerie A; Bourdel Marchasson I; Decamps A; Manciet G; Emeriau JP
    Ann Pharmacother; 1995 Jun; 29(6):634. PubMed ID: 7663042
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypercalcemia: a finding indicative of a prostatic adenocarcinoma].
    Llarena Ibarguren R; Acha Pérez M; Zabala Egurrola JA; Pertusa Peña C
    Actas Urol Esp; 1989; 13(5):409-10. PubMed ID: 2531967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis due to cyproterone acetate.
    Drakos PE; Gez E; Catane R
    Eur J Cancer; 1992; 28A(11):1931-2. PubMed ID: 1389539
    [No Abstract]   [Full Text] [Related]  

  • 20. Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study.
    Sander S; Nissen-Meyer R; Aakvaag A
    Scand J Urol Nephrol; 1982; 16(3):193-7. PubMed ID: 6219455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.